ASRX.life is an advanced access program providing enrollment in approved peptide protocols — the legal pathway to specialty compounds not available through standard prescribing.
Program members are not patients. All protocols operate under a physician-supervised framework with informed consent. This is not medical treatment.
The FDA prohibits 503A pharmacies from compounding certain peptides — including some of the most studied compounds in longevity and regenerative medicine. The legal pathway is a legitimate advanced access program.
ASRX.health handles standard telehealth — GLP-1s, TRT, hormone optimization — through licensed providers and FDA-compliant pharmacies.
ASRX.life is the advanced access arm. It operates under an approved protocol with a physician principal investigator and direct supply from ClearMeds, a domestic FDA-registered manufacturer.
Together they cover the full spectrum of peptide-based optimization — legally, transparently, and with clinical oversight at every step.
All protocols are supplied by ClearMeds, a domestic FDA-registered manufacturer. Enrollment subject to physician PI review and informed consent.
Advanced access is more structured than standard telehealth — and intentionally so. Here's what to expect.
Most providers quietly stopped offering BPC-157, CJC-1295, and similar peptides after the FDA's 2023 compounding ruling. We didn't stop — we built the right structure to continue.
Submit your application below. The physician PI will review and respond within 48–72 hours.
Your application is reviewed by the physician PI within 48–72 hours. No payment is collected until enrollment is approved and informed consent is completed.